# A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants

> **NCT05355935** · PHASE1 · COMPLETED · sponsor: **Insmed Incorporated** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Brensocatib
- **DRUG:** Moxifloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05355935
- **Lead sponsor:** Insmed Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-27
- **Primary completion:** 2022-10-07
- **Final completion:** 2022-10-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05355935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05355935, "A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05355935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*